Ikerketa proiektua
PR2005_20/01
Novel comprehensive immunotherapy to specifically target the malignant clone in Sézary syndrome, an ultra-rare cancer of mature T lymphocytes
date_range
Iraupena 2020(e)ko urtarrila-(a)k 12-(e)tik 2023(e)ko azaroa-(a)k 30-(e)ra izan da
(47 months)